<DOC>
	<DOC>NCT01390792</DOC>
	<brief_summary>The purpose of this post-marketing surveillance study is to collect information on efficacy and safety for prophylactic administration of zanamivir in clinical practice in family or persons living with patients with influenza virus infection.</brief_summary>
	<brief_title>Special Drug Use Investigation for RelenzaÂ® (Zanamivir) (Prophylaxis)</brief_title>
	<detailed_description />
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Zanamivir</mesh_term>
	<criteria>Subjects who meet the study population criteria Subjects with a history of hypersensitivity to the ingredients of zanamivir</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>